HOME >> MEDICINE >> NEWS
Researchers urge caution in using ESAs for cancer-related anemia

DURHAM, N.C., April 30 /PRNewswire/ -- Echoing recent FDA warnings, a research group from Northern Ireland cautions against over-aggressive use of a group of drugs called "erythropoiesis-stimulating agents" (ESAs) to treat anemia in some cancer patients, according to a commentary in the April issue of The Oncologist, published by AlphaMed Press.

The article by Dr. Terence R. Lappin and colleagues of Queen's University, Belfast, cites evidence that using ESAs to treat non-chemotherapy-related anemia in cancer patients could increase the risk of death, thromboembolic events, and perhaps even cancer growth. The authors write, "Overall these studies have raised concerns that ESAs could in certain circumstances adversely affect survival in cancer patients and have led to speculation that these agents may enhance thrombosis, tumor growth, and neovascularization."

The ESAs darbepoetin alfa (Aranesp) and epoetin alfa (Epogen and Procrit) are genetically engineered forms of a protein called erythropoietin, which stimulates red blood cell production. The drugs are widely used to treat anemia: low levels of hemoglobin, the oxygen-carrying protein in the blood. They are approved for use in treating anemia in patients with chronic kidney disease and in cancer patients with anemia related to chemotherapy.

However, the FDA has recently issued alerts regarding possible hazards of ESA treatment for anemia in cancer patients not receiving chemotherapy. The alerts were based on problems reported in several studies of such "off-label" use of ESAs. One study showed a 25 percent increase in the risk of death for patients receiving darbepoetin alfa. Another reported that cancer patients treated with ESAs were at much higher risk of abnormal blood clots, or "thromboembolic events" -- including stroke and myocardial infarction.

In their commentary, Dr. Lappin and coauthors draw attention to an additional possibility: that ESAs could promote cancer
'"/>

Contact: George Kendall
gkendall@alphamedpress.com
919-680-0011
AlphaMed Press, Inc.
1-May-2007


Page: 1 2

Related medicine news :

1. Researchers suggest TB screening for all international adoptees
2. Researchers find vitamin B1 deficiency key to vascular problems for diabetic patients
3. Researchers link metal ions to neurodegenerative disease
4. Researchers develop criteria to detect bone mass deficiencies in children with chronic diseases
5. Researchers call for investigation into links between khat use and psychiatric disorders
6. Researchers use MRI to predict recovery after spinal cord injury
7. Researchers find deadly prescription drug effects 6 years before FDA
8. Researchers investigate impact of lifestyle on GI health
9. Researchers begin randomized double-blind trial of airway bypass treatment for emphysema
10. Researchers discover how antibiotic inhibits bacterial growth
11. Researchers identify new therapy for patients with Crohns disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... October 08, 2019 , ... PotentiaMetrics, an ... Jerry Henderson as Chief Medical Officer. Dr. Henderson will be responsible for the ... Dr. Henderson previously served as Chair of both the Informatics Governance and the ...
(Date:10/8/2019)... MARINA DEL REY, Calif. (PRWEB) , ... October ... ... Quality Confab for laboratory managers, administrators and pathologists, 4medica® President ... Perfect Payment™ is the first-to-market solution reinventing labs orders management-by starting with ...
(Date:10/8/2019)... ... October 08, 2019 , ... Smile Brands Inc. has been named one ... Comparably. Smile Brands, a leading dental support organization with nearly 440 affiliated practices across ... Smiles for Everyone®. The Happiness Award is the latest in a series of ...
(Date:10/8/2019)... ... 2019 , ... EBSCO Information Services ( EBSCO ) has ... from Dynamic Health™ into the MCN platform. Dynamic Health is EBSCO's ... MCN provides custom policy content, document management software and compliance expertise to healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... On November 9, 2019, husband and wife ... No Cost Dental Day . 2019 marks the ninth consecutive year that Mansouri ... community who are in need. , This event has always had a great turnout, serving ...
Breaking Medicine News(10 mins):
(Date:10/15/2019)... FORESIDE, Maine (PRWEB) , ... ... ... Standards1 releases VALIDATE® LP2 linearity and calibration verification kit, for Roche cobas® ... A (Apo-A1) and Apolipoprotein B (Apo-B). Each VALIDATE® LP2 kit, liquid, ...
(Date:10/11/2019)... ... October 11, 2019 , ... Five New York fitness studios have teamed up to create ... opportunity to tour and sample a variety of the top group exercise classes offered on ... produced by Club Pilates on W. 57th St., the Hell’s Kitchen Sweat Crawl will feature ...
(Date:10/10/2019)... ... October 10, 2019 , ... Ovation Fertility is once ... of reproductive medicine, with six abstracts accepted for poster presentations at the ASRM ... October 12-16, 2019, in Philadelphia. , “Ovation will have a prominent presence in ...
Breaking Medicine Technology:
Cached News: